
卡瑞利珠单抗联合仑伐替尼或贝伐珠单抗治疗肝癌的疗效分析
Clinical efficacy of camrelizumab combined with lunvatinib or bevacizumab in the treatment of hepatocellular carcinoma
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |